Trulieve's CEO Sells into Strength: A Calculated Move Amid Cannabis Rescheduling's Windfall

Related Articles

Green Thumb Industries: A Profitable Cannabis Leader Poised for a Rescheduling-Driven Revaluation

4 days ago

What is Brookfield's Latest Strategic Move into Global Logistics

1 months ago

Is the Cannabis Industry Finally Ready for a Breakout in 2026

4 months ago

Will a New EU Windfall Tax Hit Energy Companies Hard

3 months ago

Category

You may also like

Stock News•1 week ago

Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year

Trulieve CEO sold 136,811 shares for ~$1.2M at $8.76 each on June 26, after shares surged 148% over the past year.

TRLV

Share

Stock News•3 weeks ago

The Marijuana Industry Just Had a Massive Milestone

A U.S. marijuana company began trading on the NYSE, a first for the industry. This milestone could boost sector visibility and access to capital.

TRLV

Share

Stock News•3 weeks ago

InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition

InterCure closed the first 50% tranche of its Botanico acquisition, gaining exclusive U.S. genetics and AI tech. The company also launched a strategic review of U.S.

INCR

Share

Stock News•1 months ago

Innovative Industrial Properties: The 13% Yield Just Got De-Risked, Yet The Market Is Asleep

IIPR's 13% yield appears de-risked after refinancing May debt and securing tentative re-tenanting agreements for all troubled assets, while cannabis rescheduling to Schedule III could improve tenant c...

IIPR

Share